Clinical trial
Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
NCT00230997 · Neurological Research Center, Industry · Completed
Key facts
| NCT number | NCT00230997 |
|---|---|
| Title | Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies |
| Official title | An Open Label 24-Week, Flexible Dose Trial to Assess the Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies |
| Lead sponsor | Neurological Research Center, Industry |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lewy Body Disease |
| Intervention type | Drug |
| Interventions | Galantamine |
| Enrollment | 50 |
| Start date | Dec 1, 2002 |
| Completion | Aug 1, 2004 |
| First posted | Oct 3, 2005 |
| Last update posted | Dec 16, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: